Related Experiment Video
Updated: Jun 30, 2026
04:50
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
[Smoking--a risk factor for rheumatoid arthritis development]
Anne Friesgaard Christensen1, Hanne Merete Lindegaard, Peter Junker
1Medicinsk Afdeling C, Odense Universitetshospital, DK-5000 Odense C. a.friesgaard@gmail.com
Ugeskrift for Laeger
|September 18, 2008
Summary
Smoking is a significant risk factor for developing rheumatoid arthritis (RA). It interacts with other factors like IgM-rheumatoid factor and anti-CCP, increasing RA risk, though its effect on disease progression needs more study.
Area of Science:
- Rheumatology
- Immunology
- Environmental Health
Context:
- Rheumatoid arthritis (RA) is a chronic, disabling inflammatory joint disease with complex origins.
- Both genetic predisposition and environmental exposures are implicated in RA pathogenesis.
- The specific interplay between environmental factors and genetic susceptibility in RA requires further elucidation.
Purpose:
- To investigate the interaction between smoking and rheumatoid arthritis (RA) through a comprehensive literature search.
- To synthesize current evidence on smoking as a risk factor for RA development.
- To identify knowledge gaps regarding smoking's impact on RA disease course.
Summary:
- Previous and current smoking are identified as significant risk factors for rheumatoid arthritis (RA) development.
- Smoking acts synergistically with other known RA risk factors, including IgM-rheumatoid factor (IgM-RF), anti-cyclic citrullinated peptide antibodies (anti-CCP), and shared epitope alleles.
- The literature review indicates a need for more detailed research on how smoking influences the progression and clinical course of RA.
Impact:
- Highlights smoking as a modifiable risk factor for rheumatoid arthritis (RA).
- Emphasizes the synergistic effect of smoking with specific biomarkers and genetic factors in RA etiology.
- Underscores the need for further research into smoking's role in rheumatoid arthritis (RA) disease progression and management strategies.
Related Concept Videos
01:26Stress Prevention and Stress Management Techniques IV
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation